Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Niu W, Xiao Q, Wang X, Zhu J, Li J, Liang X, Peng Y, Wu C, Lu R, Pan Y, Luo J, Zhong X, He H, Rong Z, Fan JB, Wang Y
Chemical & Handling Information Type: Synthetic dual incretin receptor agonist Targets: GIP receptor and GLP-1 receptor Appearance: White to off-white lyophilized powder Specifications Peptide: Tirzepatide Amount: 60 mg per vial Form: Lyophilized powder Purity: 99% (HPLC)
Studies have compared MT-II with PT-141 and MC4R-selective agonists to dissect MC3R versus MC4R contributions to pro-sexual effects and to characterise the role of MC1R activation in modifying central sexual behaviour biology
Not only does it demonstrates beneficial effects in regard to cardiovascular risk factors (ie, diabetes, lipid management, and weight control), but it also has been shown in animal studies to have positive cardiac effects irrespective of its effects on glucose control and weight loss
[DOI] [PubMed] [Google Scholar] 30.Bridges R.J., Natale N.R., Patel S.A
US$ 20.40
US$ 27.28
US$ 27.81
US$ 20.10
US$ 26.53
US$ 25.48
US$ 22.71
US$ 28.72
